Supplement Material
Jujube cAMP
Finished Product
Fermented Drinks
FSMP
Sports Nutrition Supplements
PKU Health Care Activities
CKD Health Care Activities
Leave Your Message
Our science-backed formulations combine precision amino acid profiling with advanced delivery technologies — engineered to support gut barrier integrity, metabolic enzyme activity, and systemic nutrient utilization.
Amino acids are far more than the building blocks of protein. Within the gastrointestinal system, specific amino acids — including glutamine, glycine, arginine, and tryptophan — serve as primary fuels for enterocytes, regulators of tight junction proteins, and modulators of the gut-associated immune network.
Metabolically, amino acids participate in every major pathway: gluconeogenesis, fatty acid oxidation, mitochondrial energy production, and the synthesis of critical enzymes and hormones. A deficiency or imbalance in even a single conditionally essential amino acid can cascade into impaired digestion, inflammatory bowel conditions, insulin resistance, or metabolic syndrome.
🔬 Key Insight: Glutamine alone accounts for over 30% of the nitrogen flux in the gut epithelium — making it the single most important amino acid for maintaining mucosal integrity and preventing leaky gut syndrome.
Modern nutraceutical science is increasingly focused on targeted amino acid supplementation — not broad-spectrum protein blends — to achieve precise physiological outcomes in digestive wellness and metabolic optimization.
Glutamine and glycine reinforce tight junctions and reduce intestinal permeability.
BCAAs and arginine drive mitochondrial biogenesis and energy substrate utilization.
Precise amino acid ratios support digestive enzyme production in the pancreas.
Tryptophan metabolites regulate serotonin and the gut-brain axis signaling network.
The global amino acid supplement market is undergoing a structural transformation — shifting from commodity bulk ingredients to precision, bioavailability-optimized nutraceutical actives targeting specific gastrointestinal and metabolic endpoints.
The global functional amino acid market reached USD 8.4 billion in 2024 and is projected to surpass USD 13.2 billion by 2030, driven by rising prevalence of IBS, metabolic syndrome, and consumer demand for gut-health nutraceuticals. Asia-Pacific leads production volume, while North America and Europe dominate premium formulation demand.
Contract manufacturers are investing heavily in fermentation-derived amino acid production, replacing chemical synthesis routes with biotechnology platforms. This shift improves purity profiles, reduces environmental burden, and enables L-isomer specificity — critical for bioavailability in digestive health applications. SINOFN's GMP-certified facilities are at the forefront of this transition.
Over 2,400 clinical trials registered globally in 2023–2025 specifically investigate amino acid interventions for gut permeability, non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and inflammatory bowel disease. Glutamine, N-acetylcysteine, and tryptophan formulations are leading the evidence base for regulatory-grade digestive health claims.
The next decade will see amino acid science converge with microbiomics, AI-driven formulation, and personalized nutrition — redefining how digestive and metabolic health products are designed and delivered.
Machine learning platforms are now capable of predicting optimal amino acid combinations for specific metabolic phenotypes. By analyzing gut microbiome sequencing data alongside metabolomic profiles, AI systems can recommend personalized amino acid blends that maximize digestive enzyme activity and minimize inflammatory markers — enabling truly individualized nutraceutical manufacturing.
Emerging research demonstrates powerful synergies between specific amino acids and postbiotic compounds. Glutamine combined with short-chain fatty acid precursors dramatically amplifies gut barrier restoration. This postbiotic-amino acid co-delivery concept is driving a new category of advanced digestive health formulations in the premium supplement market.
Enteric coating, liposomal encapsulation, and pH-responsive release systems are being applied to amino acid actives to ensure targeted delivery to specific segments of the gastrointestinal tract. Glutamine released in the jejunum versus the colon produces fundamentally different metabolic outcomes — precision delivery is the new competitive frontier.
The industry is transitioning from petrochemical and animal-derived amino acid sources to precision fermentation using engineered microorganisms. This enables vegan-certified, allergen-free amino acid actives with superior isotopic purity — meeting the dual demands of sustainability-conscious consumers and stringent regulatory frameworks in the EU and North America.
From clinical medical nutrition to sports recovery and healthy aging, amino acids are deployed across a diverse spectrum of high-value application categories — each with distinct formulation requirements and regulatory pathways.
Amino acid solutions are foundational to Total Parenteral Nutrition (TPN) and enteral nutrition formulas for post-surgical patients, ICU care, and malabsorption disorders. Glutamine-enriched TPN reduces gut bacterial translocation and ICU mortality. SINOFN's pharmaceutical-grade amino acid manufacturing supports this critical clinical segment.
BCAAs (leucine, isoleucine, valine) combined with glutamine form the cornerstone of sports nutrition for metabolic recovery. Post-exercise amino acid supplementation accelerates glycogen resynthesis, reduces exercise-induced gut permeability, and supports lean mass preservation — a USD 3.1 billion segment with strong amino acid demand.
Age-related muscle loss (sarcopenia) is directly linked to impaired amino acid absorption in the aging gut. Leucine-enriched essential amino acid formulas with digestive enzyme co-factors are proving highly effective in clinical studies. This segment is the fastest-growing amino acid application in the 55+ demographic globally.
Specific amino acid profiles — particularly branched-chain amino acid modulation and arginine supplementation — are being investigated as adjunct therapies for type 2 diabetes, NAFLD, and metabolic syndrome. Amino acid-based medical foods represent a rapidly expanding regulatory category in the US, EU, and APAC markets.
Amino acid-based infant formulas for cow's milk protein allergy (CMPA) represent a high-value clinical nutrition segment. Glycine, taurine, and cysteine are critical for neonatal bile acid conjugation and gut maturation. Hypoallergenic amino acid formulas are among the most regulated and highest-margin products in the pediatric nutrition category.
Consumer demand for functional foods fortified with digestive health amino acids is surging. Collagen peptides (glycine-rich), fermented amino acid beverages, and gut-health protein bars represent the fastest-growing retail formats. Taste masking and solubility optimization are key manufacturing challenges that SINOFN's R&D team has systematically addressed.
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group — a national high-tech enterprise founded in 2012 and backed by the Chinese Academy of Sciences. Established in 2025, we operate from Shanghai as the trading hub for global partners seeking premium, science-driven contract manufacturing services.
Our expertise spans the full spectrum of amino acid-based nutraceutical manufacturing: from raw material sourcing and fermentation-derived active development to finished product OEM/ODM delivery in capsule, tablet, powder, and liquid formats — all compliant with GMP, ISO22000, HACCP, and HALAL standards.
With deep roots in academic science and commercial manufacturing excellence, SINOFN bridges the gap between cutting-edge amino acid research and scalable, market-ready digestive and metabolic health solutions for global brands.
Welcome to our world of supplement manufacturing expertise. We are committed to delivering premium quality amino acid and digestive health products tailored to meet your brand's specific needs — from custom formula development to turnkey finished goods delivery.
Whether you need a glutamine-based gut repair formula, a BCAA metabolic complex, or a comprehensive digestive enzyme and amino acid blend — our team of PhD-level formulators and GMP-certified production engineers will transform your concept into a market-ready product.
We offer end-to-end contract manufacturing services: formula development, stability testing, regulatory documentation, private label packaging, and global logistics — all under one roof at our state-of-the-art Shanghai and Tianjin facilities.
Explore Finished Products →Sinofn prioritizes intellectual property, holding 36 patents (11 invention, 12 utility model, 11 software copyrights, 2 design) and 71 multi-category trademarks. We are certified with ISO9001, ISO22000, HACCP, and HALAL, demonstrating our commitment to quality and safety in every amino acid and digestive health formulation we produce.
GMP-Certified Supplement Manufacturing · From Formula to Finished Goods
With state-of-the-art manufacturing facilities, specialized R&D capabilities, and a robust supply chain, we ensure the highest quality standards for our clients. Our GMP certification reflects our commitment to excellence in amino acid and digestive health product manufacturing.
Founded with support from the Chinese Academy of Sciences, our research capabilities in amino acid biochemistry and digestive health science are unmatched in the contract manufacturing sector.
Our robust intellectual property portfolio in amino acid formulation and processing technology ensures our clients receive genuinely innovative, proprietary solutions — not commodity copies.
ISO9001, ISO22000, HACCP, and HALAL certifications ensure our amino acid and digestive health products meet the regulatory requirements of every major global market — from FDA to EFSA to TGA.
From amino acid raw material procurement and fermentation to finished product packaging and logistics — we deliver complete, turnkey manufacturing solutions tailored to your brand's exact specifications.
Our formulation team leverages clinical trial data, metabolomic research, and microbiome science to develop amino acid blends with measurable, validated digestive and metabolic health outcomes.
With dual facilities in Shanghai and Tianjin, we offer seamless scale-up from pilot batch to commercial production — ensuring your amino acid digestive health product reaches market on time and on budget.
Explore our comprehensive portfolio of amino acid-based digestive and metabolic health formulations — each engineered to deliver measurable clinical outcomes and brand-differentiated market positioning.
